Natural killer cell function during interferon treatment of delta hepatitis.
D000956:Antigens, Viral / Q000032:analysis; D004279:DNA, Viral / Q000032:analysis; D006509:Hepatitis B / Q000150:complications / Q000628:therapy; D006511:Hepatitis B Antigens / Q000032:analysis; D006515:Hepatitis B virus / Q000235:genetics; D003699:Hepatitis D / Q000150:complications / Q000276:immunology / Q000628:therapy*; D003698:Hepatitis Delta Virus / Q000276:immunology; D035923:Hepatitis delta Antigens; D006521:Hepatitis, Chronic / Q000628:therapy; D006801:Humans; D007370:Interferon Type I / Q000627:therapeutic use*; D007694:Killer Cells, Natural / Q000276:immunology*; D008099:Liver / Q000473:pathology; D011994:Recombinant Proteins / Q000627:therapeutic use
D000956:Antigens, Viral; D004279:DNA, Viral; D006511:Hepatitis B Antigens; D035923:Hepatitis delta Antigens; D007370:Interferon Type I; D011994:Recombinant Proteins; C442244:hepatitis delta virus large antigen